Publication Date
10-9-2024
Journal
Communications Biology
DOI
10.1038/s42003-024-06940-w
PMID
39384904
PMCID
PMC11464624
PubMedCentral® Posted Date
10-9-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, DNA Copy Number Variations, Single-Cell Analysis, Brain, Genome, Human, Nucleic Acid Amplification Techniques, Genetics of the nervous system, Neurodegenerative diseases, Next-generation sequencing, Data processing, Genomics
Abstract
The presence of somatic mutations, including copy number variants (CNVs), in the brain is well recognized. Comprehensive study requires single-cell whole genome amplification, with several methods available, prior to sequencing. Here we compare PicoPLEX with two recent adaptations of multiple displacement amplification (MDA): primary template-directed amplification (PTA) and droplet MDA, across 93 human brain cortical nuclei. We demonstrate different properties for each, with PTA providing the broadest amplification, PicoPLEX the most even, and distinct chimeric profiles. Furthermore, we perform CNV calling on two brains with multiple system atrophy and one control brain using different reference genomes. We find that 20.6% of brain cells have at least one Mb-scale CNV, with some supported by bulk sequencing or single-cells from other brain regions. Our study highlights the importance of selecting whole genome amplification method and reference genome for CNV calling, while supporting the existence of somatic CNVs in healthy and diseased human brain.
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Biomedical Informatics Commons, Genetics and Genomics Commons, Medical Genetics Commons, Medical Molecular Biology Commons, Medical Specialties Commons